Scholars@Duke

Prediction of immune checkpoint inhibitor (ICI) response in patients with urothelial cancer (UC) by a novel RNA-based ICI response signature (ICI-PRS).

Publication ,  Conference
Shepherd, J; Mayhew, G; Guo, J; Beebe, K; Eisner, JR; Milburn, MV
Published in: JOURNAL OF CLINICAL ONCOLOGY
2024

Duke Scholars

Joel Robert Eisner
Author Joel Robert Eisner Pharmacology & Cancer Biology

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2024

Volume

42

Issue

16

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shepherd, J., Mayhew, G., Guo, J., Beebe, K., Eisner, J. R., & Milburn, M. V. (2024). Prediction of immune checkpoint inhibitor (ICI) response in patients with urothelial cancer (UC) by a novel RNA-based ICI response signature (ICI-PRS). In JOURNAL OF CLINICAL ONCOLOGY (Vol. 42).
Shepherd, Jonathan, Gregory Mayhew, John Guo, Kirk Beebe, Joel Robert Eisner, and Michael Vance Milburn. “Prediction of immune checkpoint inhibitor (ICI) response in patients with urothelial cancer (UC) by a novel RNA-based ICI response signature (ICI-PRS).” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 42, 2024.
Shepherd J, Mayhew G, Guo J, Beebe K, Eisner JR, Milburn MV. Prediction of immune checkpoint inhibitor (ICI) response in patients with urothelial cancer (UC) by a novel RNA-based ICI response signature (ICI-PRS). In: JOURNAL OF CLINICAL ONCOLOGY. 2024.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2024

Volume

42

Issue

16

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences